VPC3033, identified by its CAS number 110763-24-1, is a chemical compound that falls under the category of synthetic organic compounds. It is primarily known for its application in the field of pharmaceuticals and biochemistry. The substance exhibits specific characteristics such as being a solid at room temperature, with a defined melting point and solubility profile that may vary depending on the solvent used. VPC3033 is often studied for its potential biological activity, which may include interactions with various biological targets, making it of interest in drug development. Its molecular structure includes functional groups that contribute to its reactivity and stability. Safety data sheets typically indicate that it should be handled with care, as it may pose health risks if ingested or inhaled. Overall, VPC3033 represents a compound of significant interest in research and industrial applications, particularly in the synthesis of new therapeutic agents.

VPC-3033 is an androgen receptor antagonist. It acts by inhibiting the LNCaP cell line as well as cell lines with wild-type androgen receptor.

VPC3033

110763-24-1: VPC3033, identified by its CAS number 110763-24-1, is a chemical compound that falls under the category of synthetic organic compounds. It is primarily known for its application in the field of pharmaceuticals and biochemistry. The substance exhibits specific characteristics such as being a solid at room temperature, with a defined melting point and solubility profile that may vary depending on the solvent used. VPC3033 is often studied for its potential biological activity, which may include interactions with various biological targets, making it of interest in drug development. Its molecular structure includes functional groups that contribute to its reactivity and stability. Safety data sheets typically indicate that it should be handled with care, as it may pose health risks if ingested or inhaled. Overall, VPC3033 represents a compound of significant interest in research and industrial applications, particularly in the synthesis of new therapeutic agents.

<p>VPC-3033 is an antagonist of the androgen receptor. It acts by inhibiting the LNCaP cell line as well as cell lines with the wild-type androgen receptor.</p>

CAS 110763-24-1

VPC3033

VPC-3033

Ref: TM-T26323